← Encyclopedia Cognitive and Neurological

NA Semax Amidate

🔹 What is NA Semax Amidate?

Class: N-acetylated, amidated variant of Semax — same core heptapeptide backbone (an ACTH(4-10) analog), structurally modified for improved stability. Mechanism:

  • Shares Semax’s core mechanism: supports BDNF and NGF signaling, enhances neuroplasticity, and modulates dopamine/serotonin pathways relevant to focus, mood, and cognitive resilience.
  • The N-acetyl and amidate modifications are intended to slow enzymatic breakdown compared to standard Semax, extending the peptide’s functional half-life and duration of action.
  • Positioned in the research community as a “next-generation” or enhanced version of Semax rather than a distinct mechanism — the modification is about pharmacokinetics, not a new pathway. See this site’s Semax page for the standard, unmodified version this compound is derived from.

Primary focus:

  • Cognitive enhancement — focus, memory, and learning support.
  • Neuroprotection and stress resilience, consistent with the broader Semax research profile.
  • Longer-duration alternative for those seeking to reduce dosing frequency compared to standard Semax.

🔹 Oral Dosage: Not practical; poor oral bioavailability consistent with the base Semax molecule. Intranasal delivery is standard.


🔹 Injectable / Nasal Dosage (most common) Range:

  • Intranasal dosing in the range typically discussed for Semax analogs, commonly 200–600 mcg per dose, adjusted downward relative to standard Semax given the extended duration of action.

Frequency:

  • Often dosed once or twice daily, less frequently than standard Semax due to the longer-acting modification.

Rationale: Intranasal delivery allows direct nose-to-brain uptake; the amidated, N-acetylated structure is intended to reduce the need for the more frequent redosing typical of standard Semax.


🔹 Cycle Length Common cycle length: 2–4 weeks of daily use, consistent with typical Semax-family research protocols. Off-cycle: Periodic breaks are commonly discussed to avoid diminishing returns from continuous receptor/pathway stimulation.


Educational Integration Example (nasal)

  • Example protocol: 300 mcg intranasal once daily for 3–4 weeks, chosen over standard Semax specifically for its reduced dosing frequency.
  • Sometimes discussed alongside NA Selank Amidate (Adalank) for a combined cognitive-plus-anxiolytic research approach, mirroring how standard Semax and Selank are often paired.

🔹 Stacking Strategy (Educational / Complementary) Since NA Semax Amidate shares Semax’s cognitive/neuroprotective mechanism, complementary stacks follow the same logic as standard Semax: 🔸 Anxiolytic/Nootropic Pairing:

  • Selank or Adalank (NA Selank Amidate): Complementary GABAergic/anxiolytic support alongside Semax-family cognitive effects.

🔸 General Nootropic Support:

  • Other cognition-focused peptides or nootropics may be layered depending on the specific research goal (focus vs. memory vs. stress resilience).

Rationale: As an enhanced-duration Semax variant, its stacking logic mirrors standard Semax’s — the main practical difference is frequency of dosing, not what it pairs well with.

Studied in Humans? Limited (primarily Russian research on Semax-family compounds; minimal Western clinical trials specific to this modified variant)

FDA Approved? No

Allowed for 503a Compounding Pharmacy? No

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.